Table 6.
Cumulative antibiogram based on the most frequent isolates in PNA and UTI cases
| Antibiotics | PNA N = 118 | UTI N = 136 | ||||||
|---|---|---|---|---|---|---|---|---|
|
A. baumannii
n = 42 |
S. aureus
n = 25 |
K. pneumoniae
n = 18 |
E. faecalis
n = 30 |
E. coli
n = 36 |
A. baumannii
n = 14 |
K. pneumoniae
n = 14 |
||
| Beta-lactam antibacterials: penicillins with extended spectrum, beta-lactamase resistant penicillins, combinations of penicillins incl. beta-lactamase inhibitors | ||||||||
| Piperacillin | n/a | 87% | 0% | n/a | 47% | n/a | 7% | |
| Ampicillin | n/a | 87% | n/a | 100% | 47% | n/a | n/a | |
| Ampicillin-sulbactam | n/a | 87% | 72% | 100% | 83% | n/a | 43% | |
| Amoxicillin-clavulanic acid | n/a | 87% | 44% | 100% | 83% | n/a | 57% | |
| Piperacillin-tazobactam | n/a | 87% | 50% | 100% | 92% | n/a | 57% | |
| Other beta-lactam antibacterials: second/third generation cephalosporins, carbapenems | ||||||||
| Imipenem | 12% | 87% | 94% | 0% | 100% | 0,0 | 100% | |
| Meropenem | 14% | 87% | 94% | n/a | 100% | 7% | 100% | |
| Cefuroxime | n/a | 87% | 6% | n/a | 86% | n/a | 50% | |
| Cefotaxime | n/a | 87% | 61% | n/a | 86% | n/a | 57% | |
| Ceftazidime | n/a | 87% | n/a | n/a | 86% | n/a | n/a | |
| Cefepime | n/a | 87% | 61% | n/a | 92% | n/a | 64% | |
| Ceftazidime-avibactam | n/a | 87% | 100% | n/a | n/a | n/a | 100% | |
| Aminoglycoside antibacterials | ||||||||
| Amikacin | 26% | 96% | 83% | n/a | 92% | 21% | 86% | |
| Gentamicin | 55% | 100% | 78% | 20% | 50% | 71% | 71% | |
| Tobramycin | 31% | 96% | 67% | n/a | 86% | 14% | 57% | |
| Quinolone antibacterials | ||||||||
| Ciprofloxacin | 2% | 0% | 61% | n/a | 78% | 0% | 57% | |
| Levofloxacin | 2% | 0% | 61% | n/a | 78% | 0% | 50% | |
| Moxifloxacin | n/a | 80% | n/a | n/a | n/a | n/a | n/a | |
| Other antibacterials | ||||||||
| Colistin | 95% | n/a | n/a | n/a | n/a | 93% | n/a | |
| Trimethoprim-sulfamethoxazole | 19% | 100% | 78% | n/a | 78% | 29% | 57% | |
| Fosfomycin | n/a | n/a | n/a | n/a | 100% | n/a | n/a | |
| Nitrofurantoin | n/a | n/a | n/a | 100% | 89% | n/a | n/a | |
| Nitroxoline | n/a | n/a | n/a | n/a | 100% | n/a | n/a | |
| Rifampicin | n/a | 100% | n/a | n/a | n/a | n/a | n/a | |
| Teicoplanin | n/a | 100% | n/a | 100% | n/a | n/a | n/a | |
| Vancomycin | n/a | 100% | n/a | 100% | n/a | n/a | n/a | |
| Tetracycline | n/a | 96% | n/a | n/a | n/a | n/a | n/a | |
| Tigecycline | n/a | 100% | n/a | n/a | n/a | n/a | n/a | |
| Clindamycin | n/a | 76% | n/a | n/a | n/a | n/a | n/a | |
| Erythromycin | n/a | 76% | n/a | n/a | n/a | n/a | n/a | |
| Linezolid | n/a | 100% | n/a | 100% | n/a | n/a | n/a | |
Legend: n/a: not available; PNA: pneumonia; UTI: urinary tract infection; A. baumannii, Acinetobacter baumannii; E. faecalis, Enterococcus faecalis; E.coli, Escherichia coli; K. pneumoniae, Klebsiella pneumoniae; S. aureus, Staphylococcus aureus